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Abstract
Background: Epigenetic factors, such as microRNAs, are important regulators in the self-renewal and differentiation of stem
cells and progenies. Here we investigated the microRNAs expressed in human limbal-peripheral corneal (LPC) epithelia
containing corneal epithelial progenitor cells (CEPCs) and early transit amplifying cells, and their role in corneal epithelium.
Methodology/Principal Findings: Human LPC epithelia was extracted for small RNAs or dissociated for CEPC culture. By
Agilent Human microRNA Microarray V2 platform and GeneSpring GX11.0 analysis, we found differential expression of 18
microRNAs against central corneal (CC) epithelia, which were devoid of CEPCs. Among them, miR-184 was up-regulated in
CC epithelia, similar to reported finding. Cluster miR-143/145 was expressed strongly in LPC but weakly in CC epithelia
(P=0.0004, Mann-Whitney U-test). This was validated by quantitative polymerase chain reaction (qPCR). Locked nucleic
acid-based in situ hybridization on corneal rim cryosections showed miR-143/145 presence localized to the parabasal cells of
limbal epithelium but negligible in basal and superficial epithelia. With holoclone forming ability, CEPCs transfected with
lentiviral plasmid containing mature miR-145 sequence gave rise to defective epithelium in organotypic culture and had
increased cytokeratin-3/12 and connexin-43 expressions and decreased ABCG2 and p63 compared with cells transfected
with scrambled sequences. Global gene expression was analyzed using Agilent Whole Human Genome Oligo Microarray
and GeneSpring GX11.0. With a 5-fold difference compared to cells with scrambled sequences, miR-145 up-regulated 324
genes (containing genes for immune response) and down-regulated 277 genes (containing genes for epithelial
development and stem cell maintenance). As validated by qPCR and luciferase reporter assay, our results showed miR-145
suppressed integrin b8 (ITGB8) expression in both human corneal epithelial cells and primary CEPCs.
Conclusion/Significance: We found expression of miR-143/145 cluster in human corneal epithelium. Our results also
showed that miR-145 regulated the corneal epithelium formation and maintenance of epithelial integrity, via ITGB8
targeting.
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Introduction
In adult tissue, the renewal of epithelium relies on the
population of stem cells. They generate transit-amplifying (TA)
cells, which proliferate and differentiate to stratified squamous
epithelium. Adult stem cells are usually slow-cycling in vivo whereas
TA cells are frequently dividing with short cell cycles. When
placed in culture, stem cells and TA cells generate holoclones and
paraclones respectively [1]. Corneal epithelial progenitor cells
(CEPCs) reside in the basal epithelium of limbus which is an
annulus located at the vascularized junction between transparent
cornea and opaque sclera [2]. They are characterized by a lack of
cytokeratin-3/12 and connexin-43, which are corneal differenti-
ation markers [3,4]. They undergo more frequent cell divisions
than differentiated epithelial cells and can be cultured ex vivo from
limbal tissues [5]. There has been persistent success in clinical
application of limbal grafting or autologous limbal culture cells to
restore damaged corneal epithelia [6,7].
Epigenetic factors, such as microRNAs, are known to affect
stem cell biology, including the maintenance of pluritotency and
differentiation [8,9]. MicroRNAs are small non-coding RNAs
of 20 to 25 nucleotides in length and usually act as endogenous
repressor of gene activity [10]. They bind to the 39 untranslated
region (39UTR) of target mRNAs for translational repression or
mRNA cleavage. More than 10,000 distinct microRNA sequences
from genomes of viruses, worms and mammals have been
identified through random cloning and sequencing or computa-
tional prediction (microRNA Registry, http://www.microrna.
sanger.ac.uk/sequences). In human, more than 800 microRNAs,
attributing to about 2% of known protein coding genes, are known
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target genes remain to be identified.
In mouse, miR-134 induces ES cells to differentiate towards
ectodermal lineage [11]. The miR-17-92 cluster maintains the
undifferentiated property of lung epithelial progenitor cells [12].
P63, a proliferation regulator of epithelial cells is a target gene of
miR-203 [13]. In mammalian eyes, six retina-specific microRNAs
(miR-96, 182, 183, 184, 210 and 140-AS) have been identified by
microarray analysis [14]. In human and rat retinas, eleven
microRNAs (miR-7, 7d, 23a, 29, 107, 124, 135a, 135b, 143, 200b
and 206) were identified by a target finding approach on the
39UTR of known retinal genes [15]. In mouse cornea, miR-184 is
highly enriched in basal corneal epithelium but absent in the
superficial cells of cornea, whole limbal and conjunctival epithelia
[16]. In contrast, miR-205 and 217 are present in corneal, limbal
and conjunctival epithelia, and epidermis. MiR-184 may partic-
ipate in the terminal differentiation of corneal epithelia and
antagonize with miR-205, which down-regulates SH2-containing
inositol phosphatase-2 in regulating epithelial cell proliferation
[17]. In this study, we investigated the microRNA expression in 2
anatomical distinct human corneal tissues: limbal-peripheral
corneal (LPC) epithelium containing CEPCs and central corneal
(CC) epithelium without CEPCs.
Methods
Corneal specimen collection and CEPC culture
Human corneal rims from adult donors were recruited in the
Joint Shantou International Eye Centre (JSIEC), China. The
JSIEC Independent Ethics Committee approved the study and
participants gave written informed consent. The specimens were
immediately processed for cryosectioning. LPC and CC epithelia,
separated by 1-mm in width, were dissected for small RNA
extraction (Fig. S1A). For CEPC isolation, the limbal epithelium
was digested with Dispase (50 mg/ml, Invitrogen, Carlsbad, CA,
US) and D-sorbitol (100 mM) in SHEM [DMEM/Ham’s F-12
(Invitrogen) containing 5 mg/ml transferrin, 5 mg/ml insulin,
5 ng/ml selenate, 0.1 mM ethanolamine, 0.1 mM o-phosphoetha-
nolamine, 5 mg/ml hydrocortisone, 0.5% dimethylsulfoxide,
10 ng/ml recombinant human basic fibroblast growth factor
(bFGF, Invitrogen), 10 ng/ml human epidermal growth factor
(EGF, Invitrogen), penicillin G and streptomycin sulfate (Invitro-
gen)]. The epithelium was disintegrated to single cells using
TryPLE (Invitrogen) [18] for plating out at 500 cells/cm
2 on
Primaria dish (BD, Franklin Lakes, NJ, US) cultured in CnT20
medium and supplements (CELLnTEC, Basel, Switzerland).
Holoclones formed in 7 days were harvested for CEPCs (Fig.
S1B). Unless specified, all reagents were obtained from Sigma (St
Louis, MI, US).
Microarray experiments
Total RNA was extracted by Trizol/chloroform and purified
with the RNeasy kit (Qiagen, Valencia, CA, US). RNA quantity
and integrity were examined by RNA 6000 Pico Chip Kit (Agilent,
Santa Clara, CA, US) on Agilent 2100 Bioanalyzer. RNA samples
with 28S/18S ratios in the range of 1.4 to 1.8 were used.
MicroRNA profiling was performed using Agilent Human
microRNA Microarray V2 platform, which screens for the
expression of 723 human microRNAs from Sanger database
v.10.1. For gene expression analysis, Agilent Whole Human
Genome Oligo Microarray was used. RNA samples were labeled
with cyanine-3 (Cy3) using the Agilent One–Color Labeling kit
and hybridized to the array according to the manufacturer’s
protocol. The signal was detected with an Agilent DNA
Microarray Scanner. The array data is MIAME compliant and
the raw data was deposited in NCBI Gene Expression Omnibus
(GSE24979 and GSE24980, http://www.ncbi.nlm.nih.gov/geo/).
Data normalization and analysis
The scanned images were extracted with Feature Extraction
Software 9.5.3.1 (Agilent). Background intensity and feature non-
uniform outliers were removed by standard procedures. The
processed data were imported to GeneSpring GX10.0.2 for log2
transformation. Signal cut-off measurements were less than 0.01,
and normalized to 75
th percentile of signal intensity to standardize
each chip for cross-array comparison. Differentially expressed
miRNAs were identified using unpaired Student’s t test with P
values cut off by 0.01 and fold change more than 2.0. MicroRNA
target gene prediction was performed by TargetScan algorithm.
The gene expression list was uploaded to web-based tool DAVID
(Database for Annotation, Visualization and Integrated Discovery)
V6.7 for enriched Gene Ontology terms and significant pathway
analysis. The statistically significant terms calculated by Fishers
Exact T test associated with the biological processes were selected
for comparison.
Real-time quantitative PCR
Complementary DNA (cDNA) was prepared using High
Capacity cDNA Reverse Transcription kit (Applied Biosystems,
Calsbad, CA, US) from total RNA (1 mg) using Taqman miRNA-
specific RT primer (Exiqon, Vedbaek, Denmark, Table S1) and
a cocktail containing reverse transcription buffer, dNTP mix,
recombinant RNase inhibitor, Multiscribe reverse transcriptase at
standard procedure. Real-time PCR was performed using Taq-
man Universal PCR Master Mix on PRISM 7900HT Sequence
Detection System (Applied Biosystems). Amplification of a single
fragment was confirmed by a dissociation curve with good
correlation with standards and threshold-cycle values. Gene
expression was performed by Sybr Green assay or semi-
quantitative RT-PCR and primers were listed in Table S2.
Locked nucleic acid (LNA)-based in situ hybridization
Cryosections (10 mm thick) were fixed in 4% paraformaldehyde,
acetylated with acetic anhydride/triethanolamine (Sigma) and
treated with 5 mg/ml proteinase K [19]. After pre-hybridization,
the sections were hybridized with denatured digoxigenin (DIG)-
labeled LNA-miRCURY oligo probe (Exiqon) for specific
microRNAs or scrambled sequences at 60uC for 24 hours. After
washings, signals were detected by anti-DIG-alkaline phosphatase
conjugate (Roche, Basel, Switzerland) followed by reduction with
substrate (nitroblue tetrazolium/5-bromo-4-chloro-3-indolyl phos-
phate, NBT/BCIP, Roche). The sections were counterstained
with hematoxylin before examination under light microscopy
(DMRB, Leica, Vertrieb, Germany).
Cell transfection
Human CEPCs from passage 1 holoclones were collected and
plated for transfection with lenti-miR plasmid (System Biosciences,
MountainView, CA, US) driven by CMV promoter using Lipofec-
tamine 2000 (Invitrogen). Insert sequence for pMIRH143PA-1:
59-GCGCAGCGC CCUGUUCCCAGCCUGAGGUGCAGU-
GCUGCAUCUCUGGUCAGUUGGGAGUCUGAGAUGAA-
GCACUGUAUAGCUCAGGAAGAGAGAAGUUGUUCUG-
CAG; for pMIRH145PA-1: 59-CACCUUGUCCCUCACGGG-
GUCCAGUUUUCCCAGGAAUCCCUUAGAUGCUAAGA
UGGGGAUUCCUGGAAAUACUGUCUUGAGGUCAUGGUU.
The control was pCDH-CMV-MCS-EF1-copGFP expression
MicroRNA-145 in Corneal Epithelial Differentiation
PLoS ONE | www.plosone.org 2 June 2011 | Volume 6 | Issue 6 | e21249vector (System Biosciences). The transfection efficiency was
monitored by the percentage of green fluorescent protein (GFP)
positive cells.
Immunofluorescence and western blotting
For immunofluorescence, the samples were fixed with 2%
neutral buffered paraformaldehyde and permeabilized with 0.15%
saponin (Sigma). After blocking, they were incubated with
monoclonal antibody recognizing cytokeratin-3/12 (AE5, Sigma),
connexin-43 (Cnx43, Millipore, Billerica, MA, US) or ITGB8
(Sigma), followed by fluorescein-conjugated IgG secondary
antibody (Invitrogen) and DAPI (49,6-diamidino-2-phenylindole)
staining. For western blotting, the cells were lysed in 50 mM Tris-
HCl containing 150 mM sodium chloride, 1% Nonidet P-40,
0.25% sodium deoxycholate, protease inhibitor cocktail (Roche)
and 1 mM phenylmethyl sulfonylfluoride for 30 minutes on ice.
The clear supernatant was collected for protein denaturation in a
buffer at a final concentration of 2% sodium dodecylsulfate (SDS),
50 mM DL-dithiothreitol and 1% glycerol and analyzed by 10%
SDS-PAGE (polyacrylamide gel electrophoresis) using monoclonal
antibody against Cnx-43, ABCG2 (Abcam), p63a (Cell Signaling,
Danvers, MA, US) or GAPDH (Sigma), followed by appropriate
horseradish peroxidase-conjugated Ig secondary antibodies. Stain-
ing signals were detected by enhanced chemiluminescence (ECL,
GE Healthcare). Except stated, all reagents were obtained from
Sigma.
Corneal epithelium organotypic culture
Human amniotic membrane (AM) obtained by elective
Caesarean with written consent was preserved sterile in 50%
glycerol at 280uC. Prior to culture, AM epithelium was removed
by treatment with 5 mg/ml dispase. The remaining basement
membrane and stroma were placed in a culture insert (Corning,
Corning, NY, US) with the epithelial side facing up. CEPCs
transfected with pre-miRs or scrambled sequences were seeded at
a density of 5610
4 cells/cm
2 in serum-free SHEM supplemented
with EGF and bFGF and cultured until confluence. The cell
monolayer was air-lifted with basal side nourished by culture
medium for 21 days to induce multilayer formation. The con-
structed epithelium was fixed with 10% neutral buffered for-
maldehyde, paraffin embedded and sectioned for histological exa-
mination. Sections were used for immunohistochemical staining
with anti-human ITGB8 antibody and horseradish peroxidase-
DAB (3,39-diaminobenzidine) reaction.
Luciferase reporter assay
A 5734 base-pair XhoI/Not1 fragment encompassing the full-
length 39UTR of the human ITGB8 gene was amplified by PCR,
forward primer: 59-GAAGCTCGAGCTTTCGGTGCAACT T-
CTAAA, and reverse primer: 59-ATTAGCGGCCGCGATTAA-
CACCTACTACTAAACAG. The fragment was ligated into the
XhoI/Not1 sites of psiCHECK
TM-2 vector (Promega, Madison,
WI, US) with Renilla luciferase as the primary reporter gene. The
wildtype pCHECK-ITGB8_39UTR construct was used as tem-
plate to generate specific substitution (AACT to TTCT) of miR-
145 target site using QuikChange II Site-Directed Mutagenesis kit
(Stratagene, La Jolla, CA, US) and oligonucleotides (28–34
th site:
GATTTTTAAACACTTAATGGGATTCT GGAATTGTTA-
ATAATTGC; and 4421–4427
th site: TCTCACTTTTAAACA-
AAATTTTCT GGAAAAATATTACATGG). Wildtype and
mutant constructs were verified by direct sequencing. For the
luciferase assay, HeLa cells in 24-well plates were transfected with
0.5 mg construct and 50 pmol of pre-miR-145 or scrambled sequ-
ences using Lipofectamine 2000. At 24 hours post-transfection,
cells were collected for measuring the luciferase activity by the
Dual Luciferase Reporter Assay (Promega). The experiment was
repeated 5 times. Mean activities and standard deviation were
calculated and samples compared for statistical significance using
paired Student’s t-test.
Results
Demarcation of human limbal-peripheral versus central
corneal epithelia
To assess the quality of corneal specimens, one-eighth of each
cornea rim with intact limbus was paraformaldehyde-fixed.
Cryosections were obtained for immunofluorescence of corneal
progenitor and differentiation markers, including p63a, ATP
binding cassette glycoprotein member 2 (ABCG2), cytokeratin-15
(CK15), cytokeratin-3/12 (CK3/12), Cnx43 and epidermal
growth factor receptor (EGFR) [20–23]. Those specimens
exhibiting correct expression and localization of these markers
were used for further experiments (Figure S2). The cell membrane
staining of ABCG2 was observed in limbal basal epithelial cells but
not in any of the peripheral and central corneal epithelial cells.
The nuclear p63a staining was strong in limbal basal and
suprabasal cells, gradually restricting to the basal epithelia of
peripheral and central cornea. Undifferentiated CK15 was
prominent in limbal basal, limbal suprabasal and peripheral
corneal basal epithelia but absent in central corneal basal
epithelium. Corneal differentiation marker CK3/12 was absent
in limbal basal epithelium and weak in the peripheral and central
corneal basal epithelia. Gap junction protein Cnx43 was not
expressed in most basal cells of limbus but was positive in central
cornea. Cell membranous EGFR was found in basal cells of both
limbus and cornea. The exclusive existence of p63a
strong
ABCG2
+CK3/12
2Cnx43
2 cells in basal LPC epithelia demon-
strated the existence of CEPCs. Holoclone formation was obtained
from cells dissociated from LPC but not from CC, substantiating
the presence of CEPCs in LPC (Fig. S1B).
MicroRNA profiling in human corneal epithelium
From 10 ı `m thick cryosections, LPC and CC epithelia were
dissected out as pairs and processed immediately for small RNA
extraction to preserve the in situ microRNA expression, which
could be disrupted due to in vitro manipulation. Both LPC and CC
samples were analyzed for ABCG2 and p63a expression by qPCR
and western blotting. The sample pairs with positive ABCG2
expression in LPC but negative in CC were selected for
microRNA analysis (Figs. S1C, D).
By qPCR analysis, we found similar expressions of reported
housekeeping microRNAs (U6, hsa-let-7a, miR-16 and miR-26b)
in both LPC and CC samples (hsa-miR-16 was shown in Fig. S3).
The expression of reported ES cell-specific microRNAs (hsa-miR-
302a, 302d, 320, 338, 371, 372, 373 and 373#) was also
examined. After normalization with housekeeping U6, they were
negligibly expressed in both LPC and CC samples. In addition to
miR-205 reported to express constitutively in mouse corneal,
limbal and conjunctival basal epithelia [16], we also observed
similar expressions of ocular-specific hsa-miR-182 and 204 in LPC
and CC samples (Fig. S3).
Since CEPCs are present in LPC epithelia but not in CC and
they could be regulated by microRNAs, we predicted that LPC
epithelia might contain microRNAs distinguishable from those in
CC epithelia. For microRNA profiling using microarray investi-
gation, we studied 4 pairs of LPC and CC samples showing similar
miR-205 expression levels (Fig. 1C). We identified 14 microRNAs
(miR-10b, 126, 127, 139, 142-3p, 142-5p, 143, 145, 146a, 155,
MicroRNA-145 in Corneal Epithelial Differentiation
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than in CC epithelia (P,0.05, unpaired Student’s t test) (Table 1,
Fig. 1A). Among them, miR-145 (43.6 folds, P=0.00029) and 143
(27.2 folds, P=0.0006) were the most significantly up-regulated
microRNAs in LPC epithelia. On the other hand, 4 microRNAs
(miR-149, 184, 193b and 575) were expressed 2 folds or more in
Figure 1. MicroRNA microarray analysis of human LPC and CC epithelial samples. (A) MicroRNAs expressed with .2 folds higher in LPC
compared to CC epithelia. (B) MicroRNAs expressed higher by .2 folds in CC compared to LPC epithelia. (C) miR-205 expression in both epithelia.
Data were log(2) transformed and normalized to 75
th percentile of signal intensity for standardization. Statistical significance was calculated by
unpaired Student’s t test.
doi:10.1371/journal.pone.0021249.g001
Table 1. List of candidate miRNAs identified from miRNA microarray analysis.
MicroRNAs Unpaired Student’s t-test Reported functions (incl.)
Candidate microRNAs up-regulated in LPC versus CC epithelia
1 hsa-miR-145 P=0.00029 Tumor suppressor [41], ES pluripotency [25], cardiac SMC differentiation [27]
2 hsa-miR-143 P=0.0006 Tumor suppressor [41], ES pluripotency [25], cardiac SMC differentiation [27]
3 hsa-miR-146a P=0.0078 Tumor suppressor [42], inflammation [43]
4 hsa-miR-142-3p P=0.0088 Immune reaction [44], hematopoiesis [45]
5 hsa-miR-155 P=0.0102 Cell metabolism [46], immune reaction [47], viral infection [48]
6 has-miR-10b P=0.0127 Tumorigenesis and metastasis [49]
7 hsa-miR-338 P=0.0132 Tumor suppressor [50], neurogenesis [51]
8 hsa-miR-377 P=0.0168 Extracellular matrix modelling [52]
9 hsa-miR-376a P=0.0178 No report
10 hsa-miR-142-5p P=0.021 Hematopoiesis [53]
11 hsa-miR-211 P=0.022 Tumorigenesis [54]
12 hsa-miR-126 P=0.025 Angiogenesis, cardiac development [55]
13 hsa-miR-127 P=0.0269 Tumorigenesis [56], apoptosis, organ development [57]
14 hsa-miR-139 P=0.0364 Tumorigenesis [58], FoxO1 signaling [59]
Candidate microRNAs down-regulated in LPC versus CC epithelia
1 hsa-miR-184 P=0.00005 Oncogenic [60], neural stem cell-specific [61], cornea-specific [16]
2 hsa-miR-193b P=0.0024 Tumor suppressor [62]
3 hsa-miR-149 P=0.031 No report
4 hsa-miR-575 P=0.043 No report
doi:10.1371/journal.pone.0021249.t001
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(Table 1, Fig. 1B). Among them, miR-184, as previously reported
[16], was the most significantly up-regulated microRNA in CC
epithelia (4.9 folds, P=0.00005, unpaired Student’s t test).
Elevated expression of miR-143 and miR-145 in LPC epithelia
was validated by qPCR on additional 11 pairs of human LPC and
CC epithelia. After normalization with the respective U6, DCT of
miR-143 was 5.960.8 in LPC and 11.160.9 in CC epithelia
(P=0.0006, Mann Whitney U-test) (Fig. 2A). Similarly, DCT of
miR-145 was 4.560.7 in LPC and 10.260.7 in CC epithelia
(P=0.0004, Mann Whitney U-test) (Fig. 2B). The smaller the
DCT values relative to U6, the higher the expression. With about
88% efficiency in our PCR amplification system, LPC had miR-
143 and miR-145 expressions 26.6-fold and 36.5-fold higher than
CC epithelia respectively. Such levels were comparable to the
array results described earlier.
Localization of miR-143 and miR-145 in human corneal rim
specimens was shown by LNA-based in situ hybridization. We
hybridized the corneal rim cryosections with denatured DIG-
labeled LNA-miRCURY oligo probes for miR-143 (Fig. 2C),
miR-145 (Fig. 2E), scrambled sequences (Fig. 2G) and U6
(Fig. 2H). In contrast to U6 as the positive control and scrambled
sequence as the negative control, miR-143 and miR-145 were
more intensively detected in the limbal epithelium, but low to
negligible in the corneal epithelium. Similar results were found in
4 repeated experiments. As shown in Figures 2D and F under
higher magnification, miR-143 and miR-145 were present
predominantly in the parabasal layers, with the intensity reducing
towards the superficial layers. They were not strongly expressed in
the basal layer, which contains CEPCs.
MiR-145 regulated corneal epithelial differentiation
Freshly isolated human CEPCs were cultured in CnT20
medium and cells from primary holoclones were pooled and
plated as passage 2 (P2) for transfection with lenti-miR expression
plasmid pMIRH143PA-1 or pMIRH145PA-1 at a ratio of 3 ml
Figure 2. Validation of miR-143 and miR-145 expression in limbal epithelium. By qPCR analysis, (A) miR-143 and (B) miR-145 was up-
regulated (compared to U6 expression) in LPC epithelia, when compared to CC (P,0.001, Mann Whitney U-test). Red lines indicated mean CT value. In
situ hybridization showed (C) miR-143 and (E) miR-145 in limbal epithelium, compared to (G) scrambled sequences and (H) U6. At higher
magnification, (D) miR-143 and (F) miR-145 were present in parabasal layers. Scale bars: 150 mm (C, E, G, H); 40 mm (D, F).
doi:10.1371/journal.pone.0021249.g002
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and miR-145 were shown by GFP live imaging (Figs. 3A–B, miR-
143; 3C–D, miR-145) and qPCR (Fig. 3E). The transfected cells
were kept in CnT50 medium with low bovine pituitary extract
(15 mg/ml) for optimal corneal epithelial cell growth for 2 days
followed by expression analysis. By immunofluorescence, both
miR-143 and 145-transfected cells had increased CK3/12
expression (Figs. 3G and H), when compared to cells transfected
with scrambled sequences (Fig. 3F). This was also detected by
western blotting (Fig. 3N, second panel). On the other hand, miR-
145-transfected cells showed relatively stronger Cnx-43 expression
(Fig. 3K), which was mild in cells transfected with scrambled
sequences (Fig. 3I) or miR-143 (Fig. 3J). Western blot analysis
showed Cnx-43 upregulation in CEPCs transfected with miR-145
by about 15 folds more than those with scrambled sequences
(Fig. 3L). In addition, these cells had reduced ABCG2 (Fig. 3M,
bottom panel) and p63a expression (Fig. 3N) as revealed by RT-
PCR and immunofluorescence, respectively. This expression
pattern of corneal differentiation markers, i.e., reduced ABCG2
and p63a expression, and its expression in parabasal layers of
limbal epithelium, indicated that miR-145 might be involved in
corneal epithelial differentiation. We corroborated this supposi-
tion by a three-dimensional corneal epithelial organotypic assay.
Human P2 CEPCs transfected with miR-143, miR-145 or scram-
bled sequences were expanded to monolayer cell sheet on denuded
AM in submerged culture, followed by air-lifting to induce cell
stratification. The composites were harvested for morphological
examination. The number of epithelial layer was quantified in
15 random sites along the composite to obtain the epithelium
forming efficiency. CEPCs without transfection (Fig. 4D), with
Figure 3. Transfection analysis of miR-143 and miR-145. (A–D) Human P2 CEPCs transfected with (A and B) Lenti-miR-143 and (C and D) Lenti-
miR-145. (A, C) Phase-contrast images; (B, D) live GFP imaging. (E) Overexpression levels of miR-143 and 145 in transfected CEPCs by qPCR analysis.
Amplification signals from cells with scrambled sequences (Scm) were indicated. Immunofluorescence of (F–H) cytokeratin-3/12 and (I–K) connexin-
43 in CEPCs transfected with (F, I) scrambled sequence, (G, J) Lenti-miR-143 and (H, K). (L) Western blotting and densitometry analysis of connexin-43
(Cnx43) and GAPDH in CEPCs transfected with Lenti-miR-145 or scrambled sequences. (M) RT-PCR result of integrin b8 (ITGB8), cytokeratin-3 (CK3),
ABCG2, b-actin and GAPDH in different primary CEPCs (at P2) transfected with Lenti-miR-145 or scrambled sequences. (N) Immunofluorescence of
miR-145 (revealed by GFP), p63a and nuclear DAPI stain in P2 CEPCs after Lenti-miR-145 transfection. Scale bars: (A–D) 100 mm; (F–K, N) 10 mm.
doi:10.1371/journal.pone.0021249.g003
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sequences (Fig. 4A), generated thicker epithelia. They had typi-
cal epithelial morphology with basal cuboidal-like cells next to
the basement membrane. The cells were packed and appeared
squamous in shape at the superficial layers (non-transfected:
12.561.5 layers; lipofectamine-only; 9.962.3 layers; transfected
with scrambled sequence: 10.262.4 layers) (Fig. 4F). However, this
was not observed in the epithelia generated from miR-145-
transfected CEPCs (Fig. 4B). The epithelium was degraded, thin
(5.661.3 layers) and loosened with reduced cell density. Few
cuboidal cells were found in the basal layer and cells were tends to
be flatten or squamous in shape. The epithelium generated from
miR-143-transfected CEPCs had morphology and compactness
intermediate between control and miR-145 epithelia (8.361.6
layers) (Fig. 4C). The same results were obtained in duplicated
experiments.
Transcriptional regulation by miR-145
We compared the transcription profile of human corneal
epithelial HCE cells transfected with lenti-miR-145 or with
scrambled sequences using the Agilent Whole Human Genome
Oligo Microarray platform, which screens for 41K human genes
and transcripts. In two separate array experiments, miR-145 up-
regulated 324 genes and down-regulated 277 genes by a five-fold
difference compared to cells transfected with scrambled sequences
(Tables S3A–B). Significant Gene Ontology terms enriched in the
deregulated gene sets represented immune response (P,10
27),
process (P,10
25), regulation (P,10
23), inflammatory response
(P,10
24), cell defence (P,10
25), cell apoptosis (P,10
23), cell
differentiation (P,10
23) and development (P,10
23). In addition,
differentially regulated genes with .2 folds difference could be
associated with epithelium development, cell proliferation and
differentiation (Table 2, a full list is shown in Table S4). Real-time
PCR analysis in 4 transfection experiments consistently showed
that miR-145 markedly down-regulated integrin b8, ITGB8
(P=0.00024, paired Student’s t test) and up-regulated interferon
b1 (IFNB1) (P,0.005) but not other candidate genes, such as
Wnt7A, SOCS7 and Klf4 (Fig. 5A). Similar reduction of ITGB8
expression was observed in primary human CEPCs transfected
with miR-145 (Fig. 3M). Predicted by TargetScan Human version
5.1 (http://www.targetscan.org), 2 conserved sites for miR-145
binding: 28–34
th and 4421–4427
th was found in the 39UTR,
equivalent to 3043–3049
th and 7436–7442
nd of human ITGB8
(NM_002214) (Fig. 5B). Notably, the first site is conserved in
primates only whereas the second is found among primates,
rodents and avian. Hence, influence of miR-145 on ITGB8
expression could be species-specific. To confirm miR-145
regulated ITGB8 expression by direct targeting the 39UTR, we
cloned the full-length wildtype ITGB8 39UTR fragment down-
stream of psiCHECK-2 luciferase reporter gene and introduced
mutated miR-145 target sites: 28–34
th and 4421–4427
th, by site-
directed mutagenesis. Luciferase expression, which represented
Figure 4. Corneal epithelial organotypic assay. Representative hematoxylin-eosin stained pictures from serial sections of cell-denuded AM
composite showing the thickest epithelium and the most epithelial layers. (A) CEPCs transfected with scrambled sequences, (B) CEPCs transfected
with pre-miR-145, (C) CEPCs transfected with pre-miR-143 and (D) CEPCs with Lipofectamine 2000 and (E) non-transfected CEPCs. Scale bars: 100 mm.
(F) Epithelium forming efficiency determined by the number of epithelial layers in 15 sites along the composite. * P=0.042; ** P=0.0002 (paired
Student’s t-test).
doi:10.1371/journal.pone.0021249.g004
MicroRNA-145 in Corneal Epithelial Differentiation
PLoS ONE | www.plosone.org 7 June 2011 | Volume 6 | Issue 6 | e21249promoter activity, was examined in HeLa cells co-transfected with
the vectors and pre-miR-145 or scrambled sequences. The cells
co-transfected with wildtype 39UTR and miR-145 had reduced
luminescence when compared to cells with wildtype 39UTR and
scrambled sequences (P,0.005, one-way ANOVA) (Fig. 5C).
Reduced luminescence was also found in cells co-transfected
with miR-145 and mutated 39UTR at site 28–34
th but not with
mutated site at 4421–4427
th. Immunofluorescence showed mem-
branous staining of ITGB8 in human limbal epithelium, parti-
cularly the basement membrane in contact with basal cells and
superficial cell layers (Fig. 5D). Negative staining of the parabasal
layers was coincident with positive miR-145 expression as shown
by in situ hybridization (Figs. 2E and F). ITGB8 was strongly
detected in cultured epithelia generated from CEPCs transfected
with scrambled sequences but mild in those from pre-miR-145-
transfected CEPCs (Fig. 5E).
Discussion
In this study, we found differential expressions of 18
microRNAs between human limbal-peripheral and central corneal
epithelia. Among them, miR-143 and miR-145 were expressed
predominantly in the limbal epithelium but at very low levels in
the central corneal epithelium. In primary human CEPCs,
transfection of miR-145 up-regulated cytokeratin-3/12 and
connexin-43 and concomitantly suppressed p63 and ABCG2
expression. We hypothesized that miR-145 could be an important
regulatory molecule for human corneal epithelial differentiation.
These cells developed to thinner and defective epithelium in vitro.
This morphological alteration could be caused by miR-145 via the
direct targeting on ITGB8. Meanwhile, disruption of binding site
in ITGB8 39UTR by site-directed mutagenesis eradicated the
inhibition caused by miR-145. To our knowledge, this is the first
report of microRNA regulation on human ocular cell differenti-
ation and an example that microRNA can interfere with tissue
development.
Located in human chromosome 5 and rodent chromosome 18,
miR-143/145 are co-transcribed as one microRNA cluster from
the same microRNA precursor. In a mouse model, both are
initially expressed in the developing embryonic heart, followed by
migration to smooth muscle cells of the aorta, intersomitic arteries,
esophagus, lung, colon bladder and umbilical cord at later stages
[24]. In adult mice, they are expressed in lung, skeletal muscle,
heart and skin, and most abundantly in aorta and fat. MiR-145 is
faintly expressed in self-renewing human ES cells but up-regulated
during differentiation, indicating an inductive role on ES cell
differentiation [25]. It directly targets on core plurpotency factors,
repressing Oct4, Sox2 and Klf4, which are crucial to maintain the
self-renewal and pluripotency capacity of ES cells and promote
developments of the mesoderm and ectoderm lineages [24,26–28].
A feedback mechanism has been proposed between miR-145 and
Oct4 regulation [25]. Oct4 down-regulates miR-145 expression
through repressive binding to its promoter. Hence, in ES cells,
high Oct4 level suppresses miR-145 and the cells are capable of
self-renewing. When entering into specific lineages, the differen-
tiated cells express miR-145, which promotes differentiation and
targets on Oct4 to suppress the self-renewal capability. In this
study, miR-143/145 were expressed in the limbal epithelium, in
particular the parabasal wing cell layers, but not in the central
corneal and basal limbal epithelia. The parabasal region is
enriched with proliferative TA cells with no self-renewal ability.
The absence of Oct4 facilitates miR-145 expression. Furthermore,
in normal adult CEPCs, Oct4, Sox2 and Klf4, as anticipated, are
not detectable (Fig. 5A). This restricted the proof-of-concept study
of miR-145 targets by knock-down experiments. Instead, over-
expressing miR-145 in human CEPCs promoted CK3/12 and
Cnx43 expression, which indicated the onset of corneal epithelial
differentiation. Concurrently, these cells had reduced ABCG2 and
p63 expressions, indicating their exit from stem cell proliferation
state. As shown by in vitro corneal epithelium organotypic assay, a
thinner and loosened epithelium was generated from miR-145-
transfected human CEPCs. These findings strongly indicated that
Table 2. Selected human gene/transcript changes in miR-145 transfected HCE cells, compared to scrambled sequences.
Genes/transcripts Fold changes Reported features with cornea
Upregulated, compared to scrambled control
- Interleukin 28B [IL28B] 100.5 Viral infection [63]
- Interferon b1 [IFNB1] 55.8 Infection, viral inflammation [64]
- Interferon a-inducible protein 6 [IFI6] 40.3 No information
- Endothelin converting enzyme 2 [ECE2] 7.0 Vasoconstriction [65]
- Complement component 1, q subcomponent-like 2 [C1QL2] 6.3 Inflammation
- Tumor necrosis factor a-induced protein 6 [TNFAIP6] 4.0 Angiogenesis, apoptosis, inflammation [66]
- Somatostatin receptor 4 [SSTR4] 3.9 Angiogenesis, inflammation [67]
- Retinoic acid receptor a [RARA] 2.2 Differentiation, inflammation [68]
Downregulated, compared to scrambled control
- Angiopoietin 4 [ANGPT4] 0.08 Corneal angiogenesis, wound healing [69]
- Prostate stem cell antigen [PSCA] 0.11 Cornea development [70]
- Katanin p60 subunit A-like 2 [KARNAL2] 0.19 Cornea burn wounding [71]
- Cadherin 16 [CDH16] 0.26 Corneal limbal cell marker [72]
- Integrin b8 [ITGB8] 0.4 Corneal basal cell expression [73]
- Wingless-type MMTV integration site family 7A [WNT7A] 0.43 Corneal cell proliferation and wound closure [74]
- Suppressor of cytokine signalling 7 [SOCS7] 0.45 Corneal ulceration
doi:10.1371/journal.pone.0021249.t002
MicroRNA-145 in Corneal Epithelial Differentiation
PLoS ONE | www.plosone.org 8 June 2011 | Volume 6 | Issue 6 | e21249Figure 5. Target gene identification of miR-145 in human corneal epithelium. (A) Gene expression analysis by qPCR showing that ITGB8
was significantly down-regulated (P=0.00024, paired Student’s t-test) and IFNB1 was induced after miR-145 transfection (P,0.005). Wnt7A, Klf4,
SOCS7 and FBN3 showed no changes. The dots represented DCT values (CT of transfected cells subtracted with CT of control cells). Horizontal lines
indicated mean CT values. Scm: scrambled sequences. (B) Sequences of two miR-145 binding sites located in human ITGB8 39UTR. Yellow shaded
regions represent the conserved complementary nucleotides of miR-145 seed sequence in different species. The first 28–34
th nucleotide region is
only conserved in primates whereas 4421–4427
th region is conserved in primates and rodents. (C) HeLa cells co-transfected with wildtype (WT)
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prone to differentiate, resulting in an underdeveloped epithelium
with fewer cuboidal basal cells. We have attempted to transfect
primary CEPCs by lenti-miR plasmid and observed about 70–
80% transfection efficiency according to live GFP expression. We
selected these cells for organotypic culture, which had demon-
strated the influence of miR-145 on corneal epithelium develop-
ment. Together with the reduced ITGB8 expression in the
resulting epithelium, this likely showed that some cells could
maintain miR-145 expression after culture for a month. However,
we could not determine if this was due to transfection or endo-
genous expression in cells. Further experiments using lentivirus
to obtain a long-term over-expression of miR-145 or specific
miR-145 knockdown will be carried out to study the biological
mechanism how miR-145 regulates corneal cell proliferation,
migration and differentiation. Previous study using a zebrafish
platform illustrated that miR-145 knockdown resulted in under-
developed gut and heart [29].
We observed miR-145 down-regulated ITGB8 in human
corneal epithelial cells and this might influence epithelium
development and formation. In human limbal epithelium, ITGB8
was predominantly detectable in cell-cell boundary of superficial
layers and also found scattered between cells in the basal layer.
Interestingly, it was negligibly expressed in the parabasal region
where miR-145 was detected. ITGB8, with its binding partner aV,
is expressed in normal epithelial and neuronal cells in vivo and
regulates transforming growth factor b (TGFb) activation in
various events, including cell growth, matrix modeling, epithelial-
mesenchymal homeostasis, immune regulation and vasculogenesis
[30]. Binding of Sp1, Sp3 and AP-1 transcription factors to its core
promoter regulates ITGB8 expression in a p38-dependent manner
[31]. TGFbactivation could lead to autocrine and paracrine
signaling on cell growth and matrix production, which are
important for epithelial cell adhesion and motility [32]. b8
interaction with Rho guanine nucleotide dissociation inhibitor-1
selectively stimulates Rac1, which regulates actin cytoskeleton
arrangement, an important event in cell proliferation and
differentiation [33,34]. Also, aVb8 integrin facilitates Fas
induction [35], which is crucial for cell migration, production of
inflammatory cytokines and corneal wound healing.
In addition, miR-145-transfected HCE cells had up-regulated
IFNB1, which is known with anti-inflammatory activity. The
cornea is described as ‘‘immune privilege’’, characterized by
suppression of systemic immunity after infection. This can be
associated with low vascularization, presence of Fas ligand, which
is a target of aVb8 integrin, and TRAIL molecules and inhibitory
substances in the aqueous humor [36]. As a consequence, corneal
allografts usually survive longer than allografts in other body parts
[37]. The immunologically protective mechanism in cornea can be
associated with the production of nitric oxide, which intoxicates
various pathogens [38]. Production of interleukins, interferon and
TGFb via aVb8 integrin pathway) are pathogen-induced
immunologically protective mechanism in corneal cells [39,40].
Up-regulation of IFNB1 may contribute to enhancement of anti-
inflammatory capability of corneal cells.
In conclusion, we discovered differential expression of micro-
RNAs in human limbal and corneal epithelia. MiR-145 could be
an important regulatory molecule for human corneal epithelial
progenitor cell proliferation and differentiation. It is also crucial
for the integrity of corneal epithelium, likely via ITGB8 targeting,
which will be further investigated with ITGB8 knockdown mice.
Our findings provide the first identification of microRNAs
expressed in adult tissue-specific site with regulatory effect on
tissue cell differentiation.
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pCHECK-ITGB8_39UTR and pre-miR-145 showed lower luciferase reporter activities when compared with cells transfected with scrambled sequences
(n=5) (red labels). Disruption of binding site 4421–4427
th region resulted in higher luciferase activity (blue labels) whereas mutation at 28–34
th
region had no influence and the reduced luciferase activity levels (green labels) were similar as WT. * P,0.005, as compared to scrambled control
(one-way ANOVA). (D) Immunofluorescence of ITGB8 in human limbal epithelium. Positive immunoreactivity was observed scattered in basal layer
and continuous in superficial layers. No observable expression was noted in the parabasal layers. (E) Immunoperoxidase staining of ITGB8 in
organotypic generated epithelia. Distinct ITGB8 expression was observed in epithelial layers generated from CEPCs transfected with scrambled
sequences whereas reduced expression was found in epithelia from pre-miR-145-transfected CEPCs. Scale bars (D, E): 50 mm.
doi:10.1371/journal.pone.0021249.g005
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